Skip to main contentSkip to navigation
Sirius Investors
Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics Corp.

RDTCF
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for RDTCF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
19.96M
109.5x increase over period
CAGR: +30.93%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
25.27M
373.3x increase over period
CAGR: +40.48%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Feb 28, 2026

EV/EBITDA

Distorted

-80.42x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

5.31M

EV is +26.6% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +89.5 pp vs earliest data

Additional Multiples

EV/Sales: 38.74x

Net Debt/EBITDA: -16.69x

Share count change in dataset: +44216.94%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Feb 28, 202619.96M25.27M$0.15132.95M
Feb 28, 202532.42M35.01M$0.26124.57M
Feb 29, 20242.15M4.24M$0.02104.96M
Feb 28, 2023
Feb 28, 2022
Feb 28, 2021
Feb 29, 2020
Feb 28, 2019
Sep 30, 2017
Sep 30, 2016
Sep 30, 2015
Sep 30, 2014
Sep 30, 2013
Sep 30, 2012
Sep 30, 2011
Sep 30, 2010
Sep 30, 2009
Sep 30, 2008

Enterprise Value Analysis

Price Change (Feb 2025 to Feb 2026)

The stock price has decreased from Feb 2025 to Feb 2026.
-42.30%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
15.22

Risk-Adjusted Return

The stock offers a reasonable return for its level of risk.
0.77

Market Cap Change (Feb 2025 to Feb 2026)

The company's market capitalization has decreased from Feb 2025 to Feb 2026.
-38.42%

Enterprise Value Change (Feb 2025 to Feb 2026)

The company's enterprise value has decreased from Feb 2025 to Feb 2026, suggesting a decline in the company's total economic value.
-27.81%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (18 periods), accounting for compounding effects.
30.93%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (18 periods), accounting for compounding effects.
40.48%